Vasan RS, Enserro DM, Beiser AS, Xanthakis V. Lifetime Risk of Heart Failure Among Participants in the Framingham Study. J Am Coll Cardiol. 2022 Jan 25;79(3):250–63.

Pandey A, Omar W, Ayers C, LaMonte M, Klein L, Allen NB, et al. Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction. Circulation. 2018 Apr 24;137(17):1814–23.

Chang PP, Wruck LM, Shahar E, Rossi JS, Loehr LR, Russell SD, et al. Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance. Circulation. 2018 Jul 3;138(1):12–24.

Glynn PA, Ning H, Bavishi A, Freaney PM, Shah S, Yancy CW, et al. Heart Failure Risk Distribution and Trends in the United States Population, NHANES 1999-2016. Am J Med. 2021 Mar;134(3):e153–64.

Khera R, Kondamudi N, Zhong L, Vaduganathan M, Parker J, Das SR, et al. Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016. JAMA Netw Open. 2020 Oct 1;3(10):e2022190.

Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, et al. A Contemporary Appraisal of The Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015 Jun;175(6):996–1004.

Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, et al. Temporal Trends in the Incidence and Mortality Associated with Heart Failure with Preserved and Reduced Ejection Fraction. JACC Heart Fail. 2018 Aug;6(8):678–85.

Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, et al. Classification of Heart Failure in The Atherosclerosis Risk in Communities (Aric) Study: A Comparison Of Diagnostic Criteria. Circ Heart Fail. 2012 Mar 1;5(2):152–9.

Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, et al. Lifetime Risk for Heart Failure Among White and Black Americans: Cardiovascular Lifetime Risk Pooling Project. JAm Coll Cardiol. 2013 Apr 9;61(14):1510–7.

Siontis GC, Bhatt DL, Patel CJ. Secular Trends in Prevalence of Heart Failure Diagnosis over 20 Years (from the US NHANES). Am J Cardiol. 2022 Jun 1;172:161–4.

Rethy L, Petito LC, Vu THT, Kershaw K, Mehta R, Shah NS, et al. Trends in the Prevalence of Self-reported Heart Failure by Race/Ethnicity and Age From 2001 to 2016. JAMA Cardiol. 2020 Dec 1;5(12):1425–9.

Khera R, Pandey A, Ayers CR, Agusala V, Pruitt SL, Halm EA, et al. Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings. Circ Heart Fail. 2017 Nov;10(11):e004402.

Breathett K, Sims M, Gross M, Jackson EA, Jones EJ, Navas-Acien A, et al. Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement from the American Heart Association. Circulation. 2020 Jun 23;141(25):e948–59.

Van Nuys KE, Xie Z, Tysinger B, Hlatky MA, Goldman DP. Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities. JACC Heart Fail. 2018 May;6(5):401–9.

Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement from the American Heart Association. Circ Heart Fail. 2013 May;6(3):606–19.

Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021 Mar 1;S1071-9164(21)00050-6.

Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022 May;28(5):e1-e167.

Gidding SS, Lloyd-Jones D, Lima J, Ambale-Venkatesh B, Shah SJ, Shah R, et al. Prevalence of American Heart Association Heart Failure Stages in Black and White Young and Middle-Aged Adults: The CARDIA Study. Circ Heart Fail. 2019 Sep;12(9):e005730.

Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, et al. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community. JACC Heart Fail. 2016 Oct;4(10):808–15.

Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC, et al. Prevalence and Prognostic Significance of Heart Failure Stages: Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in The Community. Circulation. 2007 Mar 27;115(12):1563–70.

Shah AM, Claggett B, Loehr LR, Chang PP, Matsushita K, Kitzman D, et al. Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study .Circulation. 2017 Jan 17;135(3):224–40.

Jia X, Al Rifai M, Ndumele CE, Virani SS, de Lemos JA, Lee E, et al. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 Apr;11(4):440–50.

Vasan RS, Musani SK, Matsushita K, Beard W, Obafemi OB, Butler KR, et al. Epidemiology of Heart Failure Stages in Middle-Aged Black People in the Community: Prevalence and Prognosis in the Atherosclerosis Risk in Communities Study.J Am Heart Assoc. 2021 May 4;10(9):e016524.

Mohebi R, Wang D, Lau ES, Parekh JK, Allen N, Psaty BM, et al. Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort. J Am Coll Cardiol. 2023 Jun 13;81(23):2231–42.

Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, et al. Temporal Trends and Patterns In Heart Failure Incidence: A Population-Based Study Of 4 Million Individuals. Lancet. 2018 Feb 10;391(10120):572–80.

Kovell LC, Juraschek SP, Russell SD. Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010. PLoS One. 2015;10(7):e0132228.

Breathett K, Leng I, Foraker RE, Abraham WT, Coker L, Whitfield KE, et al. Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women’s Health Initiative. Circ Heart Fail. 2018 May;11(5):e004642.

Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk Factors for Heart Failure: A Population-Based Case-Control Study. Am J Med. 2009 Nov;122(11):1023–8.

Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population Trends in The Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med. 2010 Jun 10;362(23):2155–65.

Gerber Y, Weston SA, Enriquez-Sarano M, Manemann SM, Chamberlain AM, Jiang R, et al. Atherosclerotic Burden and Heart Failure After Myocardial Infarction. JAMA Cardiol. 2016 May 1;1(2):156–62.

Eaton CB, Pettinger M, Rossouw J, Martin LW, Foraker R, Quddus A, et al. Risk Factors for Incident Hospitalized Heart Failure with Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women. Circ Heart Fail. 2016 Oct;9(10):e002883.

Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014 Sep 2;130(10):820–8.

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204–22.

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global Burden of Heart Failure: A Comprehensive and Updated Review Of Epidemiology. Cardiovasc Res. 2023 Jan 18;118(17):3272–87.

Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of Heart Failure. Eur J Heart Fail. 2020 Aug;22(8):1342–56.

Christiansen MN, Køber L, Weeke P, Vasan RS, Jeppesen JL, Smith JG, et al. Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012. Circulation. 2017 Mar 28;135(13):1214–23.

Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and One-Year Outcomes in Patients with Chronic Heart Failure and Preserved, Mid-Range And Reduced Ejection Fraction: An Analysis Of The Esc Heart Failure Long-Term Registry. Eur J Heart Fail. 2017 Dec;19(12):1574–85.

Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, et al. A Multinational Registry to Study the Characteristics and Outcomes of Heart Failure Patients: The Global Congestive Heart Failure (G-CHF) Registry. Am Heart J. 2020 Sep;227:56–63.

MacDonald MR, Tay WT, Teng THK, Anand I, Ling LH, Yap J, et al. Regional Variation of Mortality in Heart Failure with Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry. J Am Heart Assoc. 2020 Jan 7;9(1):e012199.

Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, et al. Clinical Characteristics of Hospitalized Heart Failure Patients with Preserved, Mid-Range, and Reduced Ejection Fractions in Japan. ESC Heart Fail. 2019 Jun;6(3):475–86.

Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, et al. Prevalence of Heart Failure and Left Ventricular Dysfunction in China: The China Hypertension Survey, 2012-2015. Eur J Heart Fail. 2019 Nov;21(11):1329–37.

Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM, et al. Predicting Heart Failure with Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes. Circ Heart Fail. 2016 Jun;9(6):10.1161/CIRCHEARTFAILURE.115.003116 e003116.

Dunlay SM, Gerber Y, Weston SA, Killian JM, Redfield MM, Roger VL. Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in The Community. Circ Heart Fail. 2009 Sep;2(5):393–400.

Djoussé L, Driver JA, Gaziano JM. Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure. JAMA. 2009 Jul 22;302(4):394–400.

Folsom AR, Shah AM, Lutsey PL, Roetker NS, Alonso A, Avery CL, et al. American Heart Association’s Life’s Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function. Am J Med. 2015 Sep;128(9):970-976.e2.

Banerjee A, Pasea L, Chung SC, Direk K, Asselbergs FW, Grobbee DE, et al. A Population-Based Study Of 92 Clinically Recognized Risk Factors for Heart Failure: Co-Occurrence, Prognosis And Preventive Potential. Eur J Heart Fail. 2022 Mar;24(3):466–80.

Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A. Worldwide Risk Factors for Heart Failure: A Systematic Review and Pooled Analysis. Int J Cardiol. 2013 Sep 30;168(2):1186–94.

Karaye KM, Dokainish H, ElSayed A, Mondo C, Damasceno A, Sliwa K, et al. Clinical Profiles and Outcomes of Heart Failure in Five African Countries: Results from INTER-CHF Study. Glob Heart. 2021;16(1):50.

Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, Psaty BM, Smith NL, Newman AB, et al. Epidemiology of Incident Heart Failure In A Contemporary Elderly Cohort: The Health, Aging, And Body Composition Study. Arch Intern Med. 2009 Apr 13;169(7):708–15.

Chamberlain AM, Boyd CM, Manemann SM, Dunlay SM, Gerber Y, Killian JM, et al. Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction. Am J Med. 2020 Jun;133(6):e237–48.

Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, et al. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement from the American Heart Association. Circulation. 2017 May 30;135(22):e1054–91.

Povysil G, Chazara O, Carss KJ, Deevi SVV, Wang Q, Armisen J, et al. Assessing the Role of Rare Genetic Variation in Patients with Heart Failure. JAMA Cardiol. 2021 Apr 1;6(4):379–86.

Michelhaugh SA, Camacho A, Ibrahim NE, Gaggin H, D’Alessandro D, Coglianese E, et al. Proteomic Signatures During Treatment in Different Stages of Heart Failure. Circ Heart Fail. 2020 Aug;13(8):e006794.

White-Williams C, Rossi LP, Bittner VA, Driscoll A, Durant RW, Granger BB, et al. Addressing Social Determinants of Health in the Care of Patients with Heart Failure: A Scientific Statement from the American Heart Association. Circulation. 2020 Jun 2;141(22):e841–63.

Vinter N, Fawzy AM, Gent D, Ding WY, Johnsen SP, Frost L, et al. Social Determinants of Health and Cardiovascular Outcomes in Patients with Heart Failure. Eur J Clin Invest. 2022 Nov;52(11):e13843.

Shirey TE, Hu Y, Ko YA, Nayak A, Udeshi E, Patel S, et al. Relation of Neighborhood Disadvantage to Heart Failure Symptoms and Hospitalizations. Am J Cardiol. 2021 Feb 1;140:83–90.

Mujahid MS, Gao X, Tabb LP, Morris C, Lewis TT. Historical Redlining and Cardiovascular Health: The Multi-Ethnic Study of Atherosclerosis. Proc Natl Acad Sci U S A. 2021 Dec 21;118(51):e2110986118.

Wang N, Hales S, Barin E, Tofler G. Characteristics and Outcome for Heart Failure Patients with Mid-Range Ejection Fraction. J Cardiovasc Med (Hagerstown). 2018 Jun;19(6):297–303.

Piña IL, Jimenez S, Lewis EF, Morris AA, Onwuanyi A, Tam E, et al. Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9. J Am Coll Cardiol. 2021 Dec 21;78(25):2589–98.

Akwo EA, Kabagambe EK, Wang TJ, Harrell FE, Blot WJ, Mumma M, et al. Heart Failure Incidence and Mortality in the Southern Community Cohort Study. Circ Heart Fail. 2017 Mar;10(3):e003553.

Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, et al. Social Determinants of Cardiovascular Disease. Circ Res. 2022 Mar 4;130(5):782–99.

Sistrunk C, Tolbert N, Sanchez-Pino MD, Erhunmwunsee L, Wright N, Jones V, et al. Impact of Federal, State, and Local Housing Policies on Disparities in Cardiovascular Disease in Black/African American Men and Women: From Policy to Pathways to Biology. Front Cardiovasc Med. 2022;9:756734.

Lippi G, Sanchis-Gomar F. Global Epidemiology and Future Trends of Heart Failure. AME Medical Journal. 2020 Jun 25 [cited 2023 Jul 9];5(0). Available from: https://amj.amegroups.org/article/view/5475

Centers for Disease Control and Prevention National Center for Health Statistics. Centers for Disease Control and Prevention. 2023 [cited 2023 Feb 2]. National Health and Nutrition Examination Survey (NHANES) Public Use Data Files. Available from: https://www.cdc.gov/nchs/nhanes/index.htm

Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of Heart Failure and Underlying Causes In 195 Countries and Territories from 1990 to 2017. Eur J Prev Cardiol. 2021 Dec 29;28(15):1682–90.

Suthahar N, Lau ES, Blaha MJ, Paniagua SM, Larson MG, Psaty BM, et al. Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers with Incident Heart Failure. J Am Coll Cardiol. 2020 Sep 22;76(12):1455–65.

Lee DS, Gona P, Albano I, Larson MG, Benjamin EJ, Levy D, et al. A Systematic Assessment of Causes of Death After Heart Failure Onset in The Community: Impact of Age at Death, Time Period, And Left Ventricular Systolic Dysfunction. Circ Heart Fail. 2011 Jan;4(1):36–43.

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-e621.

Jain V, Minhas AMK, Morris AA, Greene SJ, Pandey A, Khan SS, et al. Demographic and Regional Trends of Heart Failure-Related Mortality in Young Adults in the US, 1999-2019. JAMA Cardiol. 2022 Sep 1;7(9):900–4.

Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER) [Internet]. [cited 2023 Jul 9]. Available from: https://wonder.cdc.gov/

Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in Cardiovascular Mortality Related to Heart Failure in the United States. J Am Coll Cardiol. 2019 May 14;73(18):2354–5.

Siddiqi TJ, Khan Minhas AM, Greene SJ, Van Spall HGC, Khan SS, Pandey A, et al. Trends in Heart Failure-Related Mortality Among Older Adults in the United States From 1999-2019. JACC Heart Fail. 2022 Nov;10(11):851–9.

Tromp J, Beusekamp JC, Ouwerkerk W, van der Meer P, Cleland JGF, Angermann CE, et al. Regional Differences in Precipitating Factors of Hospitalization for Acute Heart Failure: Insights From the REPORT-HF Registry. Eur J Heart Fail. 2022 Apr;24(4):645–52.

Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global Mortality Variations in Patients with Heart Failure: Results from the International Congestive Heart Failure (INTER-CHF) Prospective Cohort Study. Lancet Glob Health. 2017 Jul;5(7):e665–72.

G-CHF Investigators, Joseph P, Roy A, Lonn E, Störk S, Floras J, et al. Global Variations in Heart Failure Etiology, Management, and Outcomes. JAMA. 2023 May 16;329(19):1650–61.

Chen J, Normand SLT, Wang Y, Krumholz HM. National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008. JAMA. 2011 Oct 19;306(15):1669–78.

Centers for Disease Control and Prevention and National Center for Health Statistics. National Vital Statistics System: Public Use Data File Documentation: Mortality Multiple Cause-Of-Death Micro-Data Files, 2017 [Internet]. 2022 [cited 2023 Feb 2]. Available from: https://www.cdc.gov/nchs/nvss/mortality_public_use_data.htm

Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, et al. Clinical Outcomes in Patients with Heart Failure Hospitalized With COVID-19. JACC Heart Fail. 2021 Jan;9(1):65–73.

Institute for Health Metrics and Evaluation. Global Burden of Disease Study. 2020 [cited 2023 Jul 9]. Cardiomyopathy and myocarditis — Level 3 cause. Available from: https://www.healthdata.org/results/gbd_summaries/2019/cardiomyopathy-and-myocarditis-level-3-cause

Centers for Disease Control and Prevention. CDC WONDER. [cited 2023 Jul 9]. Underlying Cause of Deaths, 1999-2020. Available from: https://wonder.cdc.gov/Deaths-by-Underlying-Cause.html

Pierce JB, Shah NS, Petito LC, Pool L, Lloyd-Jones DM, Feinglass J, et al. Trends in Heart Failure-Related Cardiovascular Mortality in Rural Versus Urban United States Counties, 2011-2018: A Cross-Sectional Study. PLoS One. 2021;16(3):e0246813.

Centers for Disease Control and Prevention National Center for Health Statistics. CDC WONDER. [cited 2023 Jul 9]. Multiple Cause of Death 1999-2020. Available from: https://wonder.cdc.gov/wonder/help/mcd.html

Hsich EM, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Schwamm LH, Bhatt DL, et al. Sex Differences in In-Hospital Mortality in Acute Decompensated Heart Failure With Reduced And Preserved Ejection Fraction. Am Heart J. 2012 Mar;163(3):430–7, 437.e1-3.

Hsich EM, Blackstone EH, Thuita LW, McNamara DM, Rogers JG, Yancy CW, et al. Heart Transplantation: An In-Depth Survival Analysis. JACC Heart Fail. 2020 Jul;8(7):557–68.

Ni H, Xu J. Recent Trends in Heart Failure-Related Mortality: United States, 2000-2014. NCHS Data Brief. 2015 Dec;(231):1–8.

Vasan RS, Zuo Y, Kalesan B. Divergent Temporal Trends in Morbidity and Mortality Related to Heart Failure and Atrial Fibrillation: Age, Sex, Race, and Geographic Differences in the United States, 1991-2015. J Am Heart Assoc. 2019 Apr 16;8(8):e010756.

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The Survival of Patients with Heart Failure with Preserved or Reduced Left Ventricular Ejection Fraction: An Individual Patient Data Meta-Analysis. Eur Heart J. 2012 Jul;33(14):1750–7.

Clark KAA, Reinhardt SW, Chouairi F, Miller PE, Kay B, Fuery M, et al. Trends in Heart Failure Hospitalizations in the US from 2008 to 2018. J Card Fail. 2022 Feb;28(2):171–80.

Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart Failure with Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017 Nov 14;70(20):2476–86.

Agarwal MA, Fonarow GC, Ziaeian B. National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017. JAMA Cardiol. 2021 Aug 1;6(8):952–6.

Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, et al. Trends and Characteristics of Hospitalizations for Heart Failure in the United States from 2004 to 2018. ESC Heart Fail. 2022 Apr;9(2):947–52.

Jain V, Minhas AMK, Khan SU, Greene SJ, Pandey A, Van Spall HGC, et al. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018. JACC Heart Fail. 2022 May;10(5):350–62.

Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD. National Burden of Heart Failure Events in the United States, 2006 to 2014. Circ Heart Fail. 2018 Dec;11(12):e004873.

Savitz ST, Leong T, Sung SH, Lee K, Rana JS, Tabada G, et al. Contemporary Reevaluation of Race and Ethnicity with Outcomes in Heart Failure. J Am Heart Assoc. 2021 Feb 2;10(3):e016601.

Nayak A, Hicks AJ, Morris AA. Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients. Circ Heart Fail. 2020 Aug;13(8):e007264.

Ziaeian B, Kominski GF, Ong MK, Mays VM, Brook RH, Fonarow GC. National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity. Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):e003552.

Pinheiro LC, Reshetnyak E, Sterling MR, Levitan EB, Safford MM, Goyal P. Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study. Circ Cardiovasc Qual Outcomes. 2020 Aug;13(8):e006438.

Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, et al. Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, And Stroke in the United States from 2004 to 2018. Am Heart J. 2022 Jan;243:103–9.

Elbadawi A, Dang A, Elgendy IY, Thakker R, Albaeni A, Omer MA, et al. Age-Specific Trends and Outcomes of Hospitalizations with Acute Heart Failure in the United States. Int J Cardiol. 2021 May 1;330:98–105.

Hamo CE, Fonarow GC, Greene SJ, Vaduganathan M, Yancy CW, Heidenreich P, et al. Temporal. Am Heart J. 2021 Feb;232:154–63. Trends In Risk Profiles Among Patients Hospitalized for Heart Failure

Minhas AMK, Ijaz SH, Jamal S, Dani SS, Khan MS, Greene SJ, et al. Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. Circ Heart Fail. 2022 May;15(5):e008943.

Vaduganathan M, Claggett BL, Greene SJ, Aggarwal R, Bhatt AS, McMurray JJV, et al. Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiol. 2021 Dec 1;6(12):1415–23.

Arundel C, Lam PH, Gill GS, Patel S, Panjrath G, Faselis C, et al. Systolic Blood Pressure and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. J Am Coll Cardiol. 2019 Jun 25;73(24):3054–63.

Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, et al. Systolic Blood Pressure and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. JAMA Cardiol. 2018 Apr 1;3(4):288–97.

Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, et al. Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study. JACC Heart Fail. 2021 Oct;9(10):722–32.

Global Burden of Cardiovascular Diseases Collaboration, Roth GA, Johnson CO, Abate KH, Abd-Allah F, Ahmed M, et al. The Burden of Cardiovascular Diseases Among US States, 1990-2016. JAMA Cardiol. 2018 May 1;3(5):375–89.

Glynn PA, Molsberry R, Harrington K, Shah NS, Petito LC, Yancy CW, et al. Geographic Variation in Trends and Disparities in Heart Failure Mortality in the United States, 1999 to 2017. J Am Heart Assoc. 2021 May 4;10(9):e020541.

Yu B, Akushevich I, Yashkin AP, Yashin AI, Lyerly HK, Kravchenko J. Epidemiology of Geographic Disparities in Heart Failure Among US Older Adults: A Medicare-based Analysis. BMC Public Health. 2022 Jul 1;22(1):1280.

Centers for Disease Control and Prevention. Heart Failure [Internet]. 2023 [cited 2023 Jul 9]. Available from: https://www.cdc.gov/heartdisease/heart_failure.htm

Afzal A, van Zyl J, Nisar T, Kluger AY, Jamil AK, Felius J, et al. Trends in Hospital Admissions for Systolic and Diastolic Heart Failure in the United States Between 2004 and 2017. Am J Cardiol. 2022 May 15;171:99–104.

Mohebi R, Chen C, Ibrahim NE, McCarthy CP, Gaggin HK, Singer DE, et al. Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. J Am Coll Cardiol. 2022 Aug 9;80(6):565–78.

Adapted from Global Burden of Cardiovascular Diseases Collaboration; Roth GA, Johnson CO, Abate KH, Abd-Allah F, Ahmed M, et al. The Burden of Cardiovascular Diseases Among US States, 1990-2016. JAMA Cardiol. 2018 May 1;3(5):375-389.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA Guideline for The Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239.

Fonarow GC, Yancy CW, Hernandez AF, Peterson ED, Spertus JA, Heidenreich PA. Potential Impact of Optimal Implementation of Evidence-Based Heart Failure Therapies on Mortality. Am Heart J. 2011 Jun;161(6):1024-1030.e3.

Savarese G, Kishi T, Vardeny O, Adamsson Eryd S, Bodegård J, Lund LH, et al. Heart Failure Drug Treatment-Inertia,Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 Jan;11(1):1–14.

Brownell NK, Ziaeian B, Fonarow GC. The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction. Card Fail Rev. 2021 Mar;7:e18.

Ilonze O, Free K, Breathett K. Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients. Card Fail Rev. 2022 Jan;8:e25.

Parwani P, Yancy CW. Sociodemographic Disparities in the GDMT Usage. JACC Heart Fail. 2023 Feb;11(2):173–5.

Sukumar S, Wasfy JH, Januzzi JL, Peppercorn J, Chino F, Warraich HJ. Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 May 23;81(20):2043–55.

Mwansa H, Barry I, Knapp SM, Mazimba S, Calhoun E, Sweitzer NK, et al. Association Between the Affordable Care Act Medicaid Expansion and Receipt of Cardiac Resynchronization Therapy by Race and Ethnicity. J Am Heart Assoc. 2022 Oct 4;11(19):e026766.

Farmer SA, Kirkpatrick JN, Heidenreich PA, Curtis JP, Wang Y, Groeneveld PW. Ethnic and Racial Disparities in Cardiac Resynchronization Therapy. Heart Rhythm. 2009 Mar;6(3):325–31.

Ilonze O, Free K, Shinnerl A, Lewsey S, Breathett K. Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management. Heart Fail Clin. 2023 Jul;19(3):379–90.

Breathett K, Knapp SM, Carnes M, Calhoun E, Sweitzer NK. Imbalance in Heart Transplant to Heart Failure Mortality Ratio Among African American, Hispanic, and White Patients. Circulation. 2021 Jun 15;143(24):2412–4.

Molina EJ, Shah P, Kiernan MS, Cornwell WK, Copeland H, Takeda K, et al. The Society of Thoracic Surgeons Intermacs 2020 Annual Report. Ann Thorac Surg. 2021 Mar;111(3):778–92.

Organ Procurement & Transplantation Network. National Data – Heart Transplant [Internet]. [cited 2023 Jul 9]. Available from: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#

Bhatnagar R, Fonarow GC, Heidenreich PA, Ziaeian B. Expenditure on Heart Failure in the United States: The Medical Expenditure Panel Survey 2009-2018. JACC Heart Fail. 2022 Aug;10(8):571–80.

Camplain R, Kucharska-Newton A, Loehr L, Keyserling TC, Layton JB, Wruck L, et al. Accuracy of Self-Reported Heart Failure. The Atherosclerosis Risk in Communities (ARIC) Study. J Card Fail. 2017 Nov;23(11):802–8.

Ziaeian B, Fonarow GC. Making Heart Failure Count. Eur J Heart Fail. 2021 Jun;23(6):917–8.